Repeatability of tumor blood flow quantification with 82Rubidium PET/CT in prostate cancer - a test-retest study.
Mads Ryø JochumsenKirsten BoucheloucheKatrine Bødkergaard NielsenJørgen FrøkiærMichael BorreJens SörensenLars Poulsen TolbodPublished in: EJNMMI research (2019)
Dynamic 82Rb PET/CT with kinetic modeling measures TBF in prostate cancer with high repeatability, which allows identification of blood flow changes of 32%. Static late-uptake 82Rb PET/CT is inferior, and only intra-individual blood flow changes above 51% can hence be recognized.